Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019355 · ClinicalTrials.gov registry record · Early Phase 1
Actinic Keratosis Study
A Early Phase 1 study of Actinic Keratosis, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT02019355 is a Early Phase 1 study of Actinic Keratosis that has completed, run by Washington University School of Medicine. The registered enrollment target is 132 participants, below the 181-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02019355, a Early Phase 1 study of Actinic Keratosis, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to determine the effectiveness of a new combination therapy for actinic keratosis. This study investigates a new indication for an FDA-approved topical medication, calcipotriol, for treatment of actinic keratosis, including how well it works and how safe it is when used in combination with the standard of care medication (5-fluorouracil) for the skin condition.
Conditions Studied
Interventions
- DRUG Vaseline
- DRUG 5-fluorouracil 5% cream
- DRUG Calcipotriol 0.005% ointment
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019355
The ClinicalTrials.gov registry entry for NCT02019355 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 181-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (27% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Actinic Keratosis appearing as the primary indexed condition, and to 3 interventions - of which Vaseline is the first listed.
NCT02019355 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02019355 about?
NCT02019355 is a clinical study titled "Actinic Keratosis Study". The main purpose of this study is to determine the effectiveness of a new combination therapy for actinic keratosis. This study investigates a new indication for an FDA-approved topical medication, calcipotriol, for treatment of actinic keratosis, including how well it works and how safe it is when ...
What is the current status of trial NCT02019355?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 132 participants. The study started on 2013-10. Estimated completion is 2015-03.
What conditions does trial NCT02019355 study?
This clinical trial studies the following conditions: Actinic Keratosis.
What interventions are being tested in trial NCT02019355?
The interventions under investigation include: Vaseline (DRUG), 5-fluorouracil 5% cream (DRUG), Calcipotriol 0.005% ointment (DRUG).
Who is sponsoring clinical trial NCT02019355?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02019355 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
RECRUITING · Phase 2
-
The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
RECRUITING · Phase 1
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
ACTIVE NOT RECRUITING · Phase 3
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
ACTIVE NOT RECRUITING · Phase 3
-
Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients
ACTIVE NOT RECRUITING · Phase 2
-
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.